Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice
Conclusion: This study suggests that fisetin is a potential novel treatment for alleviating hepatic lipid metabolism and improving NAFLD in mice via activation of the sirt1/AMPK and β-oxidation pathway.Cell Physiol Biochem 2018;49:1870 –1884
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Allergy & Immunology | Biochemistry | Cytology | Diets | Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Flavonoids | Fruit | High Fat | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Obesity | Physiology | Study | Urology & Nephrology | Vegetables